LogicBio Therapeutics (LOGC) Misses Q4 EPS by 52c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +42.9%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.52).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- HSBC Raises S&P500 Target to 8,100
- US consumers’ inflation outlook steady in August, Fed report shows
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
